Table 1.
Prognosis | Cancer Type | Clinical Outcome | Reference |
---|---|---|---|
Overall Survival | Breast cancer | Low | Wang et al., 2011 [4] |
High | Kuo et al., 2010 [37] | ||
High | Zeng et al., 2014 [51] | ||
Colon cancer | Low | Jiang et al., 2010 [6] | |
HCC | Low | Lee et al., 2018 [19] | |
Lung cancer | Low | Lee et al., 2010 [8] | |
High | Hua et al., 2011 [38] | ||
OSCC | High | Zeng et al., 2016 [46] | |
Osteosarcoma | Low | Chien et al., 2018 [5] | |
Invasiveness | HCC | MVI | Shim et al., 2012 [7] |
Metastasis | Breast cancer | High | Wang et al., 2011 [4] |
Low | Kuo et al., 2010 [37] | ||
Low | Zeng et al., 2011 [51] | ||
Lung cancer | Low | Hua et al., 2011 [38] | |
OSCC | Low | Zeng et al., 2016 [46] | |
Osteosarcoma | High | Chien et al., 2018 [5] | |
Recurrence | Breast cancer | High | Wang et al., 2011 [4] |
HCC | High | Lee et al., 2018 [19] | |
OSCC | Low | Zeng et al., 2016 [46] |
HCC, hepatocellular carcinoma; OSCC, oral squamous carcinoma; MVI, microvascular invasion.